TP53 and cancer: To constrain cancer growth, CAFs actively secrete IFN-β, however in cancer cells harboring TP53 mutations R175H and R248Q, mut-p53 alleviates this response via SOCS1-mediated inhibition of STAT1 phosphorylation, thereby protecting lung carcinoma cells from its anti-tumor effects (80).